SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing a massive parabolic rally as investors aggressively price in sustained supply shortages and high demand for AI-focused memory hardware, leading to intense community speculation about a looming stock split and price targets reaching into the triple digits. While the stock continues to hit all-time highs amid a broader semiconductor sector surge, the community remains sharply divided between those riding the momentum of this historic rerating and those warning that the valuation has become detached from fundamental reality.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is trending as investors rally behind its recently announced multibillion-dollar data center partnership with Cerebras Systems, fueling anticipation for upcoming growth catalysts and the pending Cerebras IPO. Community sentiment remains intensely bullish, with many traders framing current price volatility as strategic accumulation while they look toward longer-term valuation re-rates and potential institutional interest.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is surging as investors aggressively reprice the stock following a record-breaking earnings beat and massive contract backlog, fueling comparisons to industry giants and speculative meme-stock momentum. The community is heavily focused on the stock's potential for parabolic growth leading up to the upcoming SpaceX IPO, with bulls celebrating new all-time highs while debating whether to scale out or hold for long-term trend extension.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently in the spotlight as investors balance high-conviction growth narratives around its GLP-1 and peptide offerings against volatility ahead of earnings. While some community members are betting on a massive sentiment shift and potential short squeeze, others are expressing concern over price action and the impact of sector-wide regulatory developments.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing a significant surge in momentum driven by a major new defense contract and a successful earnings beat that outperformed market expectations. Community sentiment is highly bullish, with investors comparing the company's growth trajectory and specialized memory technology to broader sector peers and anticipating potential long-term expansion in AI data centers and aerospace.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech Inc. (MTEX) is currently drawing significant community attention due to its extremely low float, which traders believe makes it highly susceptible to rapid, parabolic price swings. While many participants are actively discussing the potential for a short squeeze and highlighting the stock's historical tendency for volatile upward moves, skeptics remain wary of the lack of a clear fundamental catalyst and are warning others about the risks of coordinated pump-and-dump activity.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing intense community focus following a record-breaking earnings report that showed significant revenue growth, yet the stock continues to face downward pressure and high volatility. Investors are actively debating whether the company is a prime long-term growth play poised for a recovery or if broader market manipulation and shifting consumer trends will continue to suppress the share price.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is surging as investors pivot to its new MicroLED-based optical interconnect technology, which aims to replace copper in AI data centers to resolve critical bandwidth and power bottlenecks. Community members are closely tracking the company's $15M development partnership with Fabric.AI and potential interest from major semiconductor hyperscalers, viewing these developments as a significant re-rating catalyst for the stock's long-term growth potential.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors aggressively allocate capital to capture the structural memory supercycle, viewing the fund as a direct, diversified play on the critical AI infrastructure bottleneck. Market sentiment is heavily bullish, fueled by reports of long-term supply shortages, consistent institutional inflows, and massive capacity commitments from big tech hyperscalers.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rally behind its pivot to a "Physical AI" and robotics infrastructure play, fueled by strong institutional interest and anticipation of its role in next-gen autonomous systems. Community members are actively highlighting the company's deep automotive backlog and growing cybersecurity credentials, with many expressing long-term optimism regarding a potential breakout driven by these strategic shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio.

Best Momentum Stocks to Buy for Oct. 23

PARR, CMMB and GES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 23, 2025.

New Strong Buy Stocks for Oct. 23: MQ, GES and More

MQ, GES, TRV, CMMB and PARR have been added to the Zacks Rank #1 (Strong Buy) List on Oct. 23, 2025.

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Sanofi's efdoralprin alfa meets all key endpoints in a global phase II study, showing potential as a first restorative recombinant therapy for AATD.

Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis

RHHBY secures FDA approval to expand Gazyva's label for treating lupus nephritis, offering patients a faster and more convenient treatment option.

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients

Novo Nordisk secures FDA approval for Rybelsus as the first oral GLP-1 therapy proven to cut major heart risks in adults with type II diabetes.

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

Esperion selects ESP-2001 as a preclinical candidate for primary sclerosing cholangitis, a rare liver disease, aiming to begin clinical studies in 2026.

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs 

Trump's pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility of such a development.

Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan

VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and seizure management, respectively.

CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer

Corcept files a marketing application with the EMA for relacorilant in platinum-resistant ovarian cancer after studies show survival gains.

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Chemomab Therapeutics Ltd - ADR

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$1.77
Prev Close	$1.74
Open	$1.81
Dividend Yield	0.00%
50-Day Moving Average	$1.72
Beta	1.11
Avg. Volume	37,187.56
PE Ratio	-1.19

52-Week High	$5.88
52-Week Low	$1.35
Market Capitalization	$12.51M
EPS (Annual)	-$1.42
Price to Book	1.01
Revenue Per Employee	$0.00

CMMB
Chemomab Therapeutics Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest CMMB News

CMMBChemomab Therapeutics Ltd - ADR